ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY

Purpose. To evaluate the genotype-phenotype association in Belarusian patients with non-compaction cardiomyopathy (NCCM) and clinically significant ventricular arrhythmias.Materials and methods. The study included 170 unrelated patients with NCCM prospectively observed in the RSPC “Cardiology” for 3...

Descripció completa

Dades bibliogràfiques
Autors principals:	S. M. Komissarova, N. N. Chakova, N. M. Rinejskaya, T. V. Dolmatovich, S. S. Niyazova
Format:	Article
Idioma:	Russian
Publicat:	InterMedservice 2021-05-01
Col·lecció:	Евразийский Кардиологический Журнал
Matèries:	non-compaction cardiomyopathy arrhythmic phenotype lifethreatening arrhythmias, ngs
Accés en línia:	https://www.heartj.asia/jour/article/view/6266

Ítems similars

CLINICAL CASE OF NON-COMPACTION CARDIOMYOPATHY IN A PATIENT WITH PKP2 GENE MUTATION
per: S. Komissarova, et al.
Publicat: (2020-09-01)

Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences
per: T. G. Vaykhanskaya, et al.
Publicat: (2022-11-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: James A. Coleman, et al.
Publicat: (2024-04-01)

Primary diagnosis of dilated cardiomyopathy in combination with myocardial non-compaction in an elderly patient: a case report
per: Yu. V. Vakhnenko, et al.
Publicat: (2023-06-01)

Beyond the Beat: Understanding Inherited Risk and Therapeutic Opportunities in Cardiovascular Diseases with Emphasis on Inherited Cardiomyopathies and Inherited Arrhythmic Syndromes
per: Antea Krsek, et al.
Publicat: (2024-09-01)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
per: Bin Tu, et al.
Publicat: (2021-11-01)

Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients
per: S. M. Komissarova, et al.
Publicat: (2022-05-01)

Genetic spectrum of familial and sporadic dilated cardiomyopathy: arrhythmic phenotypes associated with mutations in the lamin A/C (LMNA) gene
per: T. G. Vaikhanskaya, et al.
Publicat: (2023-05-01)

Non-compaction cardiomyopathy. Part II: limitations of imaging techniques and genetic screening, clinical observations
per: T. G. Vaikhanskaya, et al.
Publicat: (2020-12-01)

Prognostic role of atrial fibrillation in patients with non-compaction cardiomyopathy
per: S. M. Komissarova, et al.
Publicat: (2023-09-01)

Isolated non-compaction cardiomyopathy presented with ventricular tachycardia
per: Virendra C Patil, et al.
Publicat: (2011-01-01)

Comparison of frontal QRS-T angle in mitral valve prolapse without arrhythmic phenotype with healthy individuals
per: Celal Kilit
Publicat: (2024-04-01)

Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience
per: Cinzia Forleo, et al.
Publicat: (2024-06-01)

The Era of Rhythm Control: A Review of the Epidemiology and Clinical Impact of Anti-Arrhythmic Medications in Atrial Fibrillation
per: Cicely Anne Dye, et al.
Publicat: (2023-03-01)

Nucleotide sequence variant of the TPM1 gene in a family with different phenotypes of left ventricular non-compaction
per: M. M. Kudryavtseva, et al.
Publicat: (2023-01-01)

Is CRT Pro-arrhythmic? A Comparative Analysis of The Occurrence of Ventricular Arrhythmias Between Patients Implanted With CRTs and ICDs
per: A B eGopalamurugan, et al.
Publicat: (2014-09-01)

Arrhythmic Mitral Valve Prolapse: A Comprehensive Review
per: Yuyan Deng, et al.
Publicat: (2023-09-01)

The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview
per: Tadros HJ, et al.
Publicat: (2023-11-01)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
per: Linda T. Aaserud, MD, et al.
Publicat: (2024-10-01)

PORTOSYSTEMIC SHUNT OPERATIONS IN THE SURGERY OF PORTAL HYPERTENSION: FROM ECK’S FISTULA TO TIPS PROCEDURE (DEDICATED TO 100 YEARS’ JUBILEE OF MESENTERICOCAVAL SHUNT – BOGORAZ’S OPERATION)
per: Yu. V. Khoronko, et al.
Publicat: (2014-03-01)

Arrhythmic storm in postpartum lady with no structural heart disease: Case report with literature review
per: Neelam Chhabra, et al.
Publicat: (2021-05-01)

Fragmented QRS, a strong predictor of mortality and major arrhythmic events in patients with nonischemic cardiomyopathy: A systematic review and meta‐analysis
per: Moein Zangiabadian, et al.
Publicat: (2024-02-01)

POLYMORPHIC VARIANTS OF GENES CODING SYMPATHOADRENAL SYSTEM INFLUENCE ON PHENOTYPE OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
per: S. M. Komissarova, et al.
Publicat: (2015-06-01)

CLINICAL CASE OF COMBINATION OF NON-COMPACT MYOCARDIUM OF THE LEFT VENTRICLE WITH CONGENITAL ANOMALY OF THE CORONARY ARTERIES
per: Kepurko T. L., et al.
Publicat: (2019-03-01)

A rare form of cardiomyopathy: left ventricular non-compaction cardiomyopathy
per: Aditya Goud, et al.
Publicat: (2016-02-01)

Anti-arrhythmic medications increase non-cardiac mortality – A meta-analysis of randomized control trials
per: Bhavi Pandya, MBBS, et al.
Publicat: (2016-06-01)

Editorial: The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital treatment
per: Enrico Baldi, et al.
Publicat: (2024-02-01)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
per: Cristian Izquierdo, et al.
Publicat: (2021-10-01)

Prolactin Inhibition to Treat Postpartum Arrhythmic Storm
per: Miriam Compagnone, MD, et al.
Publicat: (2024-02-01)

Dexmedetomidine Exerted Anti-arrhythmic Effects in Rat With Ischemic Cardiomyopathy via Upregulation of Connexin 43 and Reduction of Fibrosis and Inflammation
per: Shu-jie Wu, et al.
Publicat: (2020-02-01)

Non-compaction cardiomyopathy. Part I: clinical and genetic heterogeneity and predictors of unfavorable prognosis
per: T. G. Vaikhanskaya, et al.
Publicat: (2020-12-01)

Pattern of delayed myocardial enhancement: A key to differentiate ischemic and non-ischemic cardiomyopathies
per: N.H. Behairy, et al.
Publicat: (2014-03-01)

Anaesthetic management of a patient with Cushing′s syndrome and non-compaction cardiomyopathy for adrenal tumour resection
per: Akilandeswari Manickam, et al.
Publicat: (2012-01-01)

Fragmented QRS on far‐field intracardiac electrograms as a predictor of arrhythmic events
per: Yuki Osaka, et al.
Publicat: (2021-10-01)

Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights
per: Francesco Vitali, et al.
Publicat: (2021-05-01)

Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol
per: Bülent Görenek, et al.
Publicat: (2024-06-01)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
per: Andraz Cerar, et al.
Publicat: (2020-06-01)

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
per: Egle Corrado, et al.
Publicat: (2020-08-01)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
per: Marcely Gimenes Bonatto, et al.
Publicat: (2020-06-01)

The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
per: E. A. Mershina, et al.
Publicat: (2015-12-01)